CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-05-18): Living donor liver transplantation linked to better survival in children

Clinical

Living donor liver transplantation linked to better survival in children

Last Updated: 2005-05-18 15:30:39 -0400 (Reuters Health)

NEW YORK (Reuters Health) - In pediatric recipients, living donor liver transplantation (LDLT) is associated with improved survival compared with deceased organ transplantation, new research indicates, and several factors may contribute to the advantage seen with LDLT.

The donor type per se may not be responsible for the survival difference. Instead, it seems to stem from inherent characteristics of LDLT recipients and the operation itself. For example, LDLT recipients are often less ill than their counterparts who receive deceased donor grafts, and the living donor grafts typically have shorter cold and warm ischemia times.

The findings, which appear in the Archives of Surgery for May, are based on an analysis of data from all 8771 pediatric liver recipients entered in the United Network for Organ Sharing (UNOS) database between October 1, 1987 and May 24, 2004.

In agreement with earlier reports, graft and patient survival rates were significantly higher in LDLT recipients compared with recipients of deceased whole or split organ grafts (p < 0.01), lead author Dr. Mary T. Austin and colleagues, from Vanderbilt University in Nashville, Tennessee, note.

For example, 5-year patient survival rates were 78% for the cohort overall, but 84% among those receiving a living donor graft.

Determinants of graft and patient survival included recipient age, race, origin of liver disease, various pretransplantation laboratory results, general medical status, multiorgan transplantation, retransplantation, ABO blood compatibility, and cold/warm ischemia times.

As noted, graft type per se did not seem to have a major impact on survival.

"Although LDLT poses risk to the donor, it is, as practiced, a valuable technique in pediatric transplantation to help overcome the critical organ shortage," the investigators conclude.

Arch Surg 2005;140:465-471.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.